← All patents

US20240325383A1

Small Molecule Targeting of BRD4 for Treatment of COVID-19

University of Texas System

Abstract

Embodiments are directed to molecules for the treatment of Coronavirus infection, including SARS-COV-2 infection. In certain aspects the small molecule is administered via inhalation and/or intranasal administration.

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Alexander Bukreyev
Priority date
March 24, 2023
Filing date
March 22, 2024
Publication date
October 03, 2024
Language
en
Metadata fetched
August 29, 2026 00:32